Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmac...
FDA Recall #D-0084-2024 — Class II — October 20, 2023
Product Description
Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-590-88
Reason for Recall
Failed Impurities/Degradation Specifications.
Recalling Firm
SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
2304 Bottles
Distribution
Nationwide within the United States
Code Information
Lot #: DNC2204A, Exp. Date 11/2023
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated